Table 3 Clinicopathological data and associations with DNA ploidy data

From: Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival

 

All cases

FCM-DNA diploid

FCM-DNA non-diploid

Pearson's χ 2

ICM-DNA diploid

ICM-DNA non-diploid

Pearson's χ 2

 

n =221 (%)

n =43 (%)

n =178 (%)

P -value

n =49 (%)

n =172 (%)

P -value

Tumour type

 Intestinal

147 (67)

28 (19)

119 (81)

0.45

32 (22)

115 (78)

0.08

 Diffuse

44 (20)

11 (25)

33 (75)

 

14 (32)

30 (68)

 

 Mixed

30 (14)

4 (13)

26 (87)

 

3 (10)

27 (90)

 

pT status

 pT1

14 (6.3%)

4 (29)

10 (71)

0.72

3 (21)

11 (79)

0.99

 pT2

86 (38.9%)

16 (19)

70 (81)

 

19 (22)

67 (78)

 

 pT3

110 (49.8%)

20 (18)

90 (82)

 

25 (23)

85 (77)

 

 pT4

11 (5.0%)

3 (27)

8 (73)

 

2 (18)

9 (82)

 

pN status

 pN0

67 (30.3%)

18 (27)

49 (73)

0.009

17 (25)

50 (75)

0.28

 pN1

96 (43.4%)

22 (23)

74 (77)

 

24 (25)

72 (75)

 

 pN2

44 (19.9%)

1 (2)

43 (98)

 

5 (11)

39 (89)

 

 pN3

14 (6.3%)

2 (14)

12 (86)

 

3 (21)

11 (79)

 

Clinical stage

 I

9 (4.1%)

8 (18)

37 (82)

0.11

7 (16)

38 (84)

0.23

 II

52 (23.5%)

14 (27)

38 (73)

 

15 (29)

37 (71)

 

 III

53 (24.0%)

10 (12)

75 (88)

 

13 (15)

72 (85)

 

 IV

27 (12.2%)

3 (11)

24 (89)

 

5 (19)

22 (82)

 

 Missing

12 (5.4%)

8

4

 

9

3

 
  1. Abbreviations: FCM-DNA, DNA ploidy status measured using flow cytometry; ICM-DNA, DNA ploidy status measured using image cytometry.
  2. Significant associations in bold.